First Analysis has made a strategic investment in TPN.health to enhance its behavioral health technology solutions and facilitate partnerships with health plans and employers, addressing critical barriers in mental health care access and provider connectivity.

Information on the target

First Analysis has made a strategic investment in TPN.health, a pioneering behavioral health technology company dedicated to enhancing the connections between providers, administrators, and employers in the realm of mental health care. TPN.health focuses on modernizing care navigation, establishing accurate provider networks, and facilitating seamless interactions among clinicians, third-party administrators (TPAs), employers, and health plans. This investment aims to bolster TPN's innovative care navigation solutions and expedite the establishment of partnerships with leading health plans and self-insured employer groups.

TPN.health operates with a provider-first, infrastructure-driven model that addresses significant barriers in behavioral health coverage, such as unreliable provider directories and long wait times. With a network of nearly 100,000 licensed clinicians and treatment providers, TPN serves over 2.2 million covered lives, positioning itself as a scalable B2B platform for behavioral health care navigation and referral management.

Industry overview in the target’s specific country

The behavioral health industry in the United States is currently navigating a complex landscape characterized by increasing demand for mental health services and persistent structural barriers. Despite the implementation of mental health parity laws, the market remains

View Source

Similar Deals

S2G Investments Faeth Therapeutics

2025

Other VC Bio Therapeutic Drugs United States of America
Marlin Equity Partners Intelligent Locations

2025

Other VC Hospitals, Clinics & Primary Care Services United States of America
Resonex Ventures OneVue

2025

Other VC Telemedicine Services United States of America
Rittenhouse Ventures S2N Health, Inc.

2025

Other VC Medical Software & Technology Services United States of America
Samsung C2N Diagnostics

2025

Other VC Bio Diagnostics & Testing United States of America
삼성물산 C2N Diagnostics

2025

Other VC Bio Diagnostics & Testing United States of America

First Analysis

invested in

TPN.health

in 2026

in a Other VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert